Prestige Consumer Healthcare Inc banner

Prestige Consumer Healthcare Inc
NYSE:PBH

Watchlist Manager
Prestige Consumer Healthcare Inc Logo
Prestige Consumer Healthcare Inc
NYSE:PBH
Watchlist
Price: 66.79 USD -0.25% Market Closed
Market Cap: $3.2B

Relative Value

The Relative Value of one PBH stock under the Base Case scenario is hidden USD. Compared to the current market price of 66.79 USD, Prestige Consumer Healthcare Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PBH Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

PBH Competitors Multiples
Prestige Consumer Healthcare Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Prestige Consumer Healthcare Inc
NYSE:PBH
3.2B USD 2.9 16.9 11.8 12.9
US
Eli Lilly and Co
NYSE:LLY
982.7B USD 15.1 47.6 32.1 34.1
US
Johnson & Johnson
NYSE:JNJ
586.1B USD 6.2 21.9 15.2 18.7
CH
Roche Holding AG
SIX:ROG
293.8B CHF 4.8 31.4 13.2 15.4
UK
AstraZeneca PLC
LSE:AZN
242.2B GBP 5.6 32.4 17.9 25.2
CH
Novartis AG
SIX:NOVN
247.3B CHF 5.7 22.8 14 18
US
Merck & Co Inc
NYSE:MRK
302.6B USD 4.7 16.6 10.3 12.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.5 13.4 9.8 11.5
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
US
Pfizer Inc
NYSE:PFE
156.1B USD 2.5 20.1 7.5 10
UK
GlaxoSmithKline PLC
LSE:GSK
91.5B GBP 2.8 16.2 8.1 11.5
P/E Multiple
Earnings Growth PEG
US
Prestige Consumer Healthcare Inc
NYSE:PBH
Average P/E: 23.9
16.9
4%
4.2
US
Eli Lilly and Co
NYSE:LLY
47.6
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
21.9
7%
3.1
CH
Roche Holding AG
SIX:ROG
31.4
29%
1.1
UK
AstraZeneca PLC
LSE:AZN
32.4
26%
1.2
CH
Novartis AG
SIX:NOVN
22.8
15%
1.5
US
Merck & Co Inc
NYSE:MRK
16.6
14%
1.2
DK
Novo Nordisk A/S
CSE:NOVO B
13.4
7%
1.9
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
US
Pfizer Inc
NYSE:PFE
20.1
26%
0.8
UK
GlaxoSmithKline PLC
LSE:GSK
16.2
18%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Prestige Consumer Healthcare Inc
NYSE:PBH
Average EV/EBITDA: 43
11.8
0%
N/A
US
Eli Lilly and Co
NYSE:LLY
32.1
18%
1.8
US
Johnson & Johnson
NYSE:JNJ
15.2
2%
7.6
CH
Roche Holding AG
SIX:ROG
13.2
5%
2.6
UK
AstraZeneca PLC
LSE:AZN
17.9
11%
1.6
CH
Novartis AG
SIX:NOVN
14
9%
1.6
US
Merck & Co Inc
NYSE:MRK
10.3
7%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.8
7%
1.4
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
-4%
N/A
UK
GlaxoSmithKline PLC
LSE:GSK
8.1
2%
4.1